The EQM BAD Index is designed to track the price movements of a portfolio of U.S.-listed companies with exposure to the following B.A.D. market segments: Betting, Alcohol/Cannabis, and Drugs (Pharmaceuticals and Biotechnology). B.A.D. companies reside in defensive, “shunned”, and underinvested segments of the market providing diversification benefits, economic resilience, and competitive risk-adjusted returns.
Quick Links
As January 3, 2024 | Index Level | 3-Month | 6-Month | 1-Year | YTD |
Price Return | 80.2 | 4.2% | -2.8% | 1.1% | -0.7% |
Total Return | |||||
Net Total Return |
Index Level | 80.2 |
---|---|
3-Month | 4.2% |
6-Month | -2.8% |
1-Year | 1.1% |
YTD | -0.7% |
Index Level | |
---|---|
3-Month | |
6-Month | |
1-Year | |
YTD |
Index Level | |
---|---|
3-Month | |
6-Month | |
1-Year | |
YTD |
As of January 3, 2024
Index Symbol (Price Return) | BADIDX |
Index Symbol (Total Return) | NA |
Index Symbol (Net Total Return) | NA |
Number of Constituents | 53 |
Market Capitalization | $3.94 Trillion |
Adjusted Market Capitalization | $78.70 |
Rebalancings | Monthly |
Dividend Yield | 1.36% |
VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.
Contact Us